8.39
0.04 (0.48%)
| Penutupan Terdahulu | 8.35 |
| Buka | 8.35 |
| Jumlah Dagangan | 582,721 |
| Purata Dagangan (3B) | 849,453 |
| Modal Pasaran | 554,163,200 |
| Harga / Pendapatan (P/E Ke hadapan) | 80.65 |
| Harga / Jualan (P/S) | 1.83 |
| Harga / Buku (P/B) | 53.71 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2026 |
| Margin Keuntungan | -20.40% |
| Margin Operasi (TTM) | -19.00% |
| EPS Cair (TTM) | -0.890 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 15.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2,353.84% |
| Nisbah Semasa (MRQ) | 2.34 |
| Aliran Tunai Operasi (OCF TTM) | -23.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.39 M |
| Pulangan Atas Aset (ROA TTM) | -9.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -949.45% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Evolus, Inc. Common Stock | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.67 |
|
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.46% |
| % Dimiliki oleh Institusi | 85.15% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |